Reported 6 months ago
The Motley Fool article discusses Pfizer's dividend payout for this year, highlighting a raise in the dividend to $0.42 per share compared to $0.41 per share last year. With an expected payout of around $9.52 billion this year, investors can anticipate significant dividends. Despite declining total sales, excluding COVID-19 products and currency exchange factors, Pfizer's revenue rose by 11% year-over-year in the first quarter of 2024. This positive outlook has led some billionaire investors to increase their holdings in Pfizer, suggesting potential growth in the company's bottom line over the next few years.
Source: YAHOO